Who owns Corvus Pharmaceuticals?

Tip: Access positions for across all investors

Analyze quarterly positions in Corvus Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Corvus Pharmaceuticals stock

Who bought or sold Corvus Pharmaceuticals this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
OrbiMed Advisors 6.9M $37M 0% Sep 2024
 View chart
Point72 Asset Management 5.6M $29M -7% Sep 2024
 View chart
Samlyn Capital 4.5M $24M -26% Sep 2024
 View chart
Vanguard Group 1.7M $3.0M 11% Jun 2024
 View chart
BlackRock 604k $3.2M 100% Sep 2024
 View chart
Geode Capital Management 563k $3.0M 22% Sep 2024
 View chart
BlackRock 562k $1.0M 7% Jun 2024
 View chart
Renaissance Technologies 387k $2.0M -31% Sep 2024
 View chart
Morgan Stanley 371k $676k 35% Jun 2024
 View chart
Schonfeld Strategic Advisors 331k $1.7M 100% Sep 2024
 View chart
Marshall Wace 323k $1.7M 333% Sep 2024
 View chart
Susquehanna International 301k $1.6M 448% Sep 2024
 View chart
Ikarian Capital 218k $1.2M 100% Sep 2024
 View chart
Citadel Advisors 182k $960k 138% Sep 2024
 View chart
Connor, Clark & Lunn Investment Management 137k $724k 65% Sep 2024
 View chart
Bridgeway Capital Management 127k $232k -43% Jun 2024
 View chart
Citigroup 123k $649k 100% Sep 2024
 View chart
State Street Corporation 120k $219k 0% Jun 2024
 View chart
TowerView 118k $620k -71% Sep 2024
 View chart
Two Sigma Advisers 113k $206k -39% Jun 2024
 View chart
Northern Trust 106k $557k 62% Sep 2024
 View chart
Acadian Asset Management 80k $420k 100% Sep 2024
 View chart
Jackson Square Capital 64k $337k 0% Sep 2024
 View chart
Jane Street 50k $265k 100% Sep 2024
 View chart
Hikari Power 50k $264k 0% Sep 2024
 View chart
Jpmorgan Chase & Co 50k $262k 441% Sep 2024
 View chart
Two Sigma Investments 48k $87k -53% Jun 2024
 View chart
Wolverine Trading 42k $214k 100% Sep 2024
 View chart
Mission Wealth Management 40k $211k 100% Sep 2024
 View chart
Gillespie Robinson & Grimm 28k $146k 138% Sep 2024
 View chart
Ancora Advisors 23k $123k 100% Sep 2024
 View chart
Quinn Opportunity Partners 22k $41k 0% Jun 2024
 View chart
Commerce Bank N A 20k $106k 0% Sep 2024
 View chart
American Century Companies 18k $96k 0% Sep 2024
 View chart
Oppenheimer & Co 17k $90k 100% Sep 2024
 View chart
Advisor Group Holdings 17k $88k 1294% Sep 2024
 View chart
Virtu Financial 16k $83k 100% Sep 2024
 View chart
Charles Schwab Investment Management 16k $83k 0% Sep 2024
 View chart
Tower Research Capital 15k $28k 33% Jun 2024
 View chart
Dimensional Fund Advisors 12k $63k 0% Sep 2024
 View chart
Two Sigma Securities 11k $21k 100% Jun 2024
 View chart
Whittier Trust Co. of Nevada 11k $59k 0% Sep 2024
 View chart
Nwam 10k $53k 100% Sep 2024
 View chart
Cubist Systematic Strategies 10k $53k -59% Sep 2024
 View chart
Resources Investment Advisors 10k $53k -31% Sep 2024
 View chart
Masso Torrence Wealth Management 10k $18k 0% Jun 2024
 View chart
Rothschild Investment 7.0k $37k 0% Sep 2024
 View chart
Simplex Trading 5.7k $29k 156% Sep 2024
 View chart
Group One Trading 5.6k $29k 100% Sep 2024
 View chart
Northwest Capital Management 3.4k $18k 0% Sep 2024
 View chart
Bnp Paribas Arbitrage, Snc 3.1k $16k 100% Sep 2024
 View chart
Western Pacific Wealth Management 2.0k $11k 100% Sep 2024
 View chart
Rhumbline Advisers 791.00 $4.2k 0% Sep 2024
 View chart
Bank of America Corporation 409.00 $2.2k 4% Sep 2024
 View chart
IFP Advisors 24.00 $43.999200 0% Jun 2024
 View chart
Parallel Advisors 20.00 $106.000000 0% Sep 2024
 View chart
Barclays 1.00 $0 0% Sep 2024
 View chart

Who sold out of Corvus Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Millennium Management Jun 2024 205k $372k
Royal Bank of Canada Jun 2024 7.2k $17k
Qube Research & Technologies Mar 2024 2.4k $4.2k
ICA Group Wealth Management Mar 2024 165.00 $293.997000